Cargando…

Differential Effects of IGF-1R Small Molecule Tyrosine Kinase Inhibitors BMS-754807 and OSI-906 on Human Cancer Cell Lines

SIMPLE SUMMARY: We have tested the effects of IGF-1R tyrosine kinase inhibitors BMS-754807 (BMS) and OSI-906 (OSI) on human colon, pancreatic carcinoma cell, and glioblastoma cell lines and primary cultures. Although OSI and BMS are able to inhibit IGF-1R activity at low doses, the differential effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuentes-Baile, María, Ventero, María P., Encinar, José A., García-Morales, Pilar, Poveda-Deltell, María, Pérez-Valenciano, Elizabeth, Barberá, Víctor M., Gallego-Plazas, Javier, Rodríguez-Lescure, Álvaro, Martín-Nieto, José, Saceda, Miguel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763458/ https://www.ncbi.nlm.nih.gov/pubmed/33322337 http://dx.doi.org/10.3390/cancers12123717

Ejemplares similares

PDGFR and IGF-1R Inhibitors Induce a G2/M Arrest and Subsequent Cell Death in Human Glioblastoma Cell Lines
por: Carrasco-Garcia, Estefania, et al.
Publicado: (2018)

Cell Death Mechanisms Induced by CLytA-DAAO Chimeric Enzyme in Human Tumor Cell Lines
por: Fuentes-Baile, María, et al.
Publicado: (2020)

Metabolic recovery of lipodystrophy, liver steatosis, and pancreatic β cell proliferation after the withdrawal of OSI-906
por: Tajima, Kazuki, et al.
Publicado: (2017)

CLytA-DAAO, Free and Immobilized in Magnetic Nanoparticles, Induces Cell Death in Human Cancer Cells
por: Fuentes-Baile, María, et al.
Publicado: (2020)

BMS-754807 is cytotoxic to non-small cell lung cancer cells and enhances the effects of platinum chemotherapeutics in the human lung cancer cell line A549
por: Franks, S. Elizabeth, et al.
Publicado: (2016)

A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer
por: Chiappori, Alberto A., et al.
Publicado: (2016)

A High-Throughput In Vitro Drug Screen in a Genetically Engineered Mouse Model of Diffuse Intrinsic Pontine Glioma Identifies BMS-754807 as a Promising Therapeutic Agent
por: Halvorson, Kyle G., et al.
Publicado: (2015)

CLytA-DAAO Chimeric Enzyme Bound to Magnetic Nanoparticles. A New Therapeutical Approach for Cancer Patients?
por: Fuentes-Baile, María, et al.
Publicado: (2021)

Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3
por: Ventero, Maria Paz, et al.
Publicado: (2019)

Combination Treatment of OSI-906 with Aurora B Inhibitor Reduces Cell Viability via Cyclin B1 Degradation-Induced Mitotic Slippage
por: Ikeda, Yuki, et al.
Publicado: (2021)

In vivo analysis of insulin-like growth factor type 1 receptor humanized monoclonal antibody MK-0646 and small molecule kinase inhibitor OSI-906 in colorectal cancer
por: LEIPHRAKPAM, PREMILA D., et al.
Publicado: (2014)

Dapagliflozin: BMS 512148; BMS-512148
Publicado: (2012)

Is OSI too late?
por: Carpenter, B E
Publicado: (1989)

Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung cancer
por: Ciuleanu, Tudor-Eliade, et al.
Publicado: (2017)

Mechanism Based Quality Control (MBQC) of Herbal Products: A Case Study YIV-906 (PHY906)
por: Lam, Wing, et al.
Publicado: (2018)

Workshop on the Use of OSI for Libraries
por: Cailloux, J M
Publicado: (1989)

Data communications, computer networks and OSI
por: Halsall, Fred
Publicado: (1988)

A Phase I Dose‐Escalation Study of Linsitinib (OSI‐906), a Small‐Molecule Dual Insulin‐Like Growth Factor‐1 Receptor/Insulin Receptor Kinase Inhibitor, in Combination with Irinotecan in Patients with Advanced Cancer
por: Davis, S. Lindsey, et al.
Publicado: (2018)

Correction: Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3
por: Ventero, Maria Paz, et al.
Publicado: (2019)

Crystal structures of trimeric HIV Env with entry inhibitors BMS-378806 and BMS-626529
por: Pancera, Marie, et al.
Publicado: (2017)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Sistema interactivo del modelo de referencia OSI /
por: Contreras Martínez, Ruth Selene
Publicado: (2004)

Next stop OSI: transition to DECnet phase V
por: Heagerty, D
Publicado: (1990)

OSI explained: end-to-end computer communication standards
por: Henshall, John, et al.
Publicado: (1988)

HGUE-C-1 is an atypical and novel colon carcinoma cell line
por: Grasso, Silvina, et al.
Publicado: (2015)

Carpal Tunnel Syndrome: The Role of Occupational Factors Among 906 Workers
por: Ghasemi, Mohammad, et al.
Publicado: (2012)

Construction of the MPI BMS Prototype Chamber
por: Bratzler, U, et al.
Publicado: (1997)

MON-906 MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A: Familiar Case Report
por: Sousa, Barbara K P, et al.
Publicado: (2020)

OSI-NSAP: un indirizzamento gerarchico per il garr
por: Delpino, F, et al.
Publicado: (1995)

Fantasia in C minor, BWV906 Fifteen two-part inventions ; Fifteen three-part sinfonias (inventions) ; Chromatic fantasia and fugue : in D minor, BWV903 /
por: Bach, Johann Sebastian, 1685-1750
Publicado: (1994)

906 How Mandatory Public Reporting Undermines Infection Prevention: An Ethnographic Study
por: Szymczak, Julia E., et al.
Publicado: (2014)

SUN-906 To Function or Not to Function: A Rare Case of Metachronous Hormone Syndrome
por: Amine, Adele, et al.
Publicado: (2020)

BMS1 Is Mutated in Aplasia Cutis Congenita
por: Marneros, Alexander G.
Publicado: (2013)

Systemic BCG‐osis following intravesical BCG instillation for bladder carcinoma
por: Liaw, Frank, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_aa77coube0ppheqikalgf6vker